BAFF induces spleen CD4+ T cell proliferation by down-regulating phosphorylation of FOXO3A and activates cyclin D2 and D3 expression

Biochemical and Biophysical Research Communications

Volumn 425, Issue 4, 2012, Pages 854-858

  Ji, Fang ^a   Chen, Rongjing ^a   Liu, Baojun ^b   Zhang, Xiaoping ^c   Han, Junli ^a   Wang, Haining ^a   Shen, Gang ^a   Tao, Jiang ^a  

^a SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

^b FUDAN UNIVERSITY   (China)

^c TONGJI UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

CD4+ T cells; Cyclin D2; Cyclin D3; Phosphorylated FOXO3A; Spleen

Indexed keywords

B CELL ACTIVATING FACTOR; CYCLIN D2; CYCLIN D3; TRANSCRIPTION FACTOR FKHRL1;

ANIMAL CELL; ARTICLE; CD4+ T LYMPHOCYTE; CELL PROLIFERATION; CONTROLLED STUDY; DOWN REGULATION; ENZYME ACTIVATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; SPLEEN; WESTERN BLOTTING;

ANIMALS; B-CELL ACTIVATING FACTOR; CD4-POSITIVE T-LYMPHOCYTES; CELL PROLIFERATION; CYCLIN D2; CYCLIN D3; DOWN-REGULATION; FORKHEAD TRANSCRIPTION FACTORS; HUMANS; MICE; MICE, INBRED ICR; PHOSPHORYLATION; SPLEEN;

EID: 84865958150     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2012.08.003     Document Type: Article

References (28)

1. Bossen C., Schneider P. BAFF, APRIL and their receptors: structure, function and signaling. Semin. Immunol. 2006, 18:263-275.
2. Mackay F., Mackay C.R. The role of BAFF in B-cell maturation, T-cell activation and autoimmunity. Trends Immunol. 2002, 23:113-115.
3. Mackay F., Schneider P., Rennert P., Browning J. BAFF AND APRIL: a tutorial on B cell survival. Annu. Rev. Immunol. 2003, 21:231-264.
4. Moore P.A., Belvedere O., Orr A., Pieri K., LaFleur D.W., Feng P., Soppet D., Charters M., Gentz R., Parmelee D., Li Y., Galperina O., Giri J., Roschke V., Nardelli B., Carrell J., Sosnovtseva S., Greenfield W., Ruben S.M., Olsen H.S., Fikes J., Hilbert D.M. BLyS: member of the tumor necrosis factor family and B lymphocyte stimulator. Science 1999, 285:260-263.
5. Schneider P. The role of APRIL and BAFF in lymphocyte activation. Curr. Opin. Immunol. 2005, 17:282-289.
6. Xia X.Z., Treanor J., Senaldi G., Khare S.D., Boone T., Kelley M., Theill L.E., Colombero A., Solovyev I., Lee F., McCabe S., Elliott R., Miner K., Hawkins N., Guo J., Stolina M., Yu G., Wang J., Delaney J., Meng S.Y., Boyle W.J., Hsu H. TACI is a TRAF-interacting receptor for TALL-1, a tumor necrosis factor family member involved in B cell regulation. J. Exp. Med. 2000, 192:137-143.
7. + T lymphocytes as well as NK cells in mice. Physiol. Res. 2006, 55:301-307.
8. L. Wen, S.J. Chen, W. Zhang, H.W. Ma, S.Q. Zhang, and L. Chen, hsBAFF regulates proliferation and response in cultured CD4(+) T lymphocytes by upregulation of intracellular free Ca(2+) homeostasis. Cytokine 53 215-22.
9. H. Tran, A. Brunet, E.C. Griffith, and M.E. Greenberg, The many forks in FOXO's road. Sci. STKE 2003 (2003) RE5.
10. Nakae J., Biggs W.H., Kitamura T., Cavenee W.K., Wright C.V., Arden K.C., Accili D. Regulation of insulin action and pancreatic beta-cell function by mutated alleles of the gene encoding forkhead transcription factor Foxo1. Nat. Genet. 2002, 32:245-253.
11. Schmidt M., Fernandez de Mattos S., van der Horst A., Klompmaker R., Kops G.J., Lam E.W., Burgering B.M., Medema R.H. Cell cycle inhibition by Foxo forkhead transcription factors involves downregulation of cyclin D. Mol. Cell. Biol. 2002, 22:7842-7852.
12. Tran H., Brunet A., Grenier J.M., Datta S.R., Fornace A.J., DiStefano P.S., Chiang L.W., Greenberg M.E. DNA repair pathway stimulated by the forkhead transcription factor FOXO3a through the Gadd45 protein. Science 2002, 296:530-534.
13. Chiles T.C. Regulation and function of cyclin D2 in B lymphocyte subsets. J. Immunol. 2004, 173:2901-2907.
14. Ciemerych M.A., Kenney A.M., Sicinska E., Kalaszczynska I., Bronson R.T., Rowitch D.H., Gardner H., Sicinski P. Development of mice expressing a single D-type cyclin. Genes Dev. 2002, 16:3277-3289.
15. Solvason N., Wu W.W., Parry D., Mahony D., Lam E.W., Glassford J., Klaus G.G., Sicinski P., Weinberg R., Liu Y.J., Howard M., Lees E. Cyclin D2 is essential for BCR-mediated proliferation and CD5 B cell development. Int. Immunol. 2000, 12:631-638.
16. + T cells during viral infection. J. Immunol. 2001, 166:795-799.
17. Ma J., Xie Y., Shi Y., Qin W., Zhao B., Jin Y. Glucocorticoid-induced apoptosis requires FOXO3A activity. Biochem. Biophys. Res. Commun. 2008, 377:894-898.
18. Potente M., Urbich C., Sasaki K., Hofmann W.K., Heeschen C., Aicher A., Kollipara R., DePinho R.A., Zeiher A.M., Dimmeler S. Involvement of Foxo transcription factors in angiogenesis and postnatal neovascularization. J. Clin. Invest. 2005, 115:2382-2392.
19. Sunters A., Fernandez de Mattos S., Stahl M., Brosens J.J., Zoumpoulidou G., Saunders C.A., Coffer P.J., Medema R.H., Coombes R.C., Lam E.W. Foxo3a transcriptional regulation of Bim controls apoptosis in paclitaxel-treated breast cancer cell lines. J. Biol. Chem. 2003, 278:49795-49805.
20. Brunet A., Bonni A., Zigmond M.J., Lin M.Z., Juo P., Hu L.S., Anderson M.J., Arden K.C., Blenis J., Greenberg M.E. Akt promotes cell survival by phosphorylating and inhibiting a Forkhead transcription factor. Cell 1999, 96:857-868.
21. N. Chapuis, S. Park, L. Leotoing, J. Tamburini, F. Verdier, V. Bardet, A.S. Green, L. Willems, F. Agou, N. Ifrah, F. Dreyfus, G. Bismuth, V. Baud, C. Lacombe, P. Mayeux, and D. Bouscary, IkappaB kinase overcomes PI3K/Akt and ERK/MAPK to control FOXO3a activity in acute myeloid leukemia. Blood 116 4240-50.
22. Herzog S., Reth M., Jumaa H. Regulation of B-cell proliferation and differentiation by pre-B-cell receptor signalling. Nat. Rev. Immunol. 2009, 9:195-205.
23. Bartkova J., Lukas J., Strauss M., Bartek J. Cyclin D3: requirement for G1/S transition and high abundance in quiescent tissues suggest a dual role in proliferation and differentiation. Oncogene 1998, 17:1027-1037.
24. Cheung T.H., Yu M.M., Lo K.W., Yim S.F., Chung T.K., Wong Y.F. Alteration of cyclin D1 and CDK4 gene in carcinoma of uterine cervix. Cancer Lett. 2001, 166:199-206.
25. Houldsworth J., Reuter V., Bosl G.J., Chaganti R.S. Aberrant expression of cyclin D2 is an early event in human male germ cell tumorigenesis. Cell Growth Differ. 1997, 8:293-299.
26. Sicinska E., Aifantis I., Le Cam L., Swat W., Borowski C., Yu Q., Ferrando A.A., Levin S.D., Geng Y., von Boehmer H., Sicinski P. Requirement for cyclin D3 in lymphocyte development and T cell leukemias. Cancer Cell 2003, 4:451-461.
27. Fernandez de Mattos S., Essafi A., Soeiro I., Pietersen A.M., Birkenkamp K.U., Edwards C.S., Martino A., Nelson B.H., Francis J.M., Jones M.C., Brosens J.J., Coffer P.J., Lam E.W. Foxo3a and BCR-ABL regulate cyclin D2 transcription through a STAT5/BCL6-dependent mechanism. Mol. Cell. Biol. 2004, 24:10058-10071.
28. Medema R.H., Kops G.J., Bos J.L., Burgering B.M. AFX-like Forkhead transcription factors mediate cell-cycle regulation by Ras and PKB through p27kip1. Nature 2000, 404:782-787.